Malden, MA, United States of America

Deepak Reyon

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Deepak Reyon

Introduction

Deepak Reyon is a notable inventor based in Malden, MA, who has made significant contributions to the field of biotechnology. With a focus on genome editing and protein engineering, Reyon has developed innovative solutions that have the potential to impact medical treatments.

Latest Patents

Reyon holds two patents that showcase his expertise and creativity. His first patent involves transcription activator-like effector (TALE) - lysine-specific demethylase 1 (LSD1) fusion proteins. This invention includes fusion proteins that comprise a DNA binding domain, such as a TAL effector repeat array or zinc finger array, along with a catalytic domain that catalyzes histone demethylation. The methods of use for these proteins are also detailed in the patent. His second patent focuses on CRISPR/Cas-related methods and compositions for treating cystic fibrosis. This invention discloses genome editing systems and compositions that target the cystic fibrosis transmembrane conductance regulator (CFTR) gene and the sodium channel epithelial 1 alpha (SCNN1A) gene. It includes a Cas9 molecule and a gRNA molecule that is complementary to the target sequences, along with methods for using these systems to prevent or treat cystic fibrosis and related diseases.

Career Highlights

Throughout his career, Deepak Reyon has worked with prominent organizations in the biotechnology sector. He has been associated with Editas Medicine, Inc., a company known for its pioneering work in genome editing, and The General Hospital Corporation, which is recognized for its contributions to medical research and healthcare.

Collaborations

Reyon has collaborated with notable individuals in his field, including Morgan Lee Maeder and Ari E Friedland. These collaborations have likely contributed to the advancement of his research and innovations.

Conclusion

Deepak Reyon is a distinguished inventor whose work in genome editing and protein engineering has the potential to revolutionize treatments for genetic disorders. His patents reflect a commitment to advancing biotechnology and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…